Sergio Schuler

Sergio Schuler has had a diverse range of roles and experiences throughout their career. Sergio has held executive positions at various companies in the animal nutrition and health industry, including DSM-Firmenich and Elanco. Sergio has also been involved in the development of innovative treatments at PhageLab. In addition, they have held leadership roles within industry associations, such as GTPS-BRSL and SINDAN. Prior to their involvement in the animal health industry, Sergio worked in sales and marketing at Roche and served as a business consultant at Arthur Andersen.

Sergio Schuler completed their Master in Business Administration (MBA) from The University of Chicago Booth School of Business between 2005 and 2007. Prior to that, they pursued a degree in Biotechnology, Dipl Sc Natw, from ETH Zürich, which they completed from 1992 to 1997.